Annual Operating Expenses
$391.32 M
-$70.97 M-15.35%
December 31, 2024
Summary
- As of March 10, 2025, CRSP annual total operating expenses is $391.32 million, with the most recent change of -$70.97 million (-15.35%) on December 31, 2024.
- During the last 3 years, CRSP annual operating expenses has fallen by -$47.06 million (-10.73%).
- CRSP annual operating expenses is now -30.54% below its all-time high of $563.35 million, reached on December 31, 2022.
Performance
CRSP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$99.59 M
+$611.00 K+0.62%
December 31, 2024
Summary
- As of March 10, 2025, CRSP quarterly total operating expenses is $99.59 million, with the most recent change of +$611.00 thousand (+0.62%) on December 31, 2024.
- Over the past year, CRSP quarterly operating expenses has increased by +$459.00 thousand (+0.46%).
- CRSP quarterly operating expenses is now -33.38% below its all-time high of $149.50 million, reached on June 30, 2022.
Performance
CRSP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CRSP Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.3% | +0.5% |
| 3 y3 years | -10.7% | +0.5% |
| 5 y5 years | +61.1% | +0.5% |
CRSP Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.5% | at low | -33.4% | +6.4% |
| 5 y | 5-year | -30.5% | +61.1% | -33.4% | +50.8% |
| alltime | all time | -30.5% | +5804.9% | -33.4% | +1505.7% |
CRISPR Therapeutics AG Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $391.32 M(-15.4%) | $99.59 M(+0.6%) |
| Sep 2024 | - | $98.98 M(-0.2%) |
| Jun 2024 | - | $99.13 M(+5.9%) |
| Mar 2024 | - | $93.62 M(-15.2%) |
| Dec 2023 | $462.29 M(-17.9%) | $110.42 M(+1.3%) |
| Sep 2023 | - | $108.99 M(-9.6%) |
| Jun 2023 | - | $120.59 M(-1.4%) |
| Mar 2023 | - | $122.30 M(-1.9%) |
| Dec 2022 | $563.35 M(+28.5%) | $124.72 M(-13.2%) |
| Sep 2022 | - | $143.62 M(-3.9%) |
| Jun 2022 | - | $149.50 M(+2.7%) |
| Mar 2022 | - | $145.50 M(+15.3%) |
| Dec 2021 | $438.38 M(+23.5%) | $126.22 M(+18.3%) |
| Sep 2021 | - | $106.71 M(-3.5%) |
| Jun 2021 | - | $110.64 M(+16.7%) |
| Mar 2021 | - | $94.80 M(-12.2%) |
| Dec 2020 | $354.98 M | $107.95 M(+16.6%) |
| Sep 2020 | - | $92.55 M(+14.6%) |
| Jun 2020 | - | $80.73 M(+9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $73.74 M(+11.7%) |
| Dec 2019 | $242.85 M(+49.8%) | $66.03 M(-9.3%) |
| Sep 2019 | - | $72.77 M(+31.6%) |
| Jun 2019 | - | $55.30 M(+13.4%) |
| Mar 2019 | - | $48.75 M(+7.5%) |
| Dec 2018 | $162.07 M(+53.4%) | $45.34 M(-9.3%) |
| Sep 2018 | - | $49.99 M(+30.3%) |
| Jun 2018 | - | $38.37 M(+35.3%) |
| Mar 2018 | - | $28.36 M(-9.6%) |
| Dec 2017 | $105.64 M(+44.1%) | $31.35 M(+20.8%) |
| Sep 2017 | - | $25.96 M(+4.3%) |
| Jun 2017 | - | $24.89 M(+6.1%) |
| Mar 2017 | - | $23.45 M(-15.2%) |
| Dec 2016 | $73.29 M(+182.2%) | $27.65 M(+71.1%) |
| Sep 2016 | - | $16.16 M(-6.9%) |
| Jun 2016 | - | $17.35 M(+43.1%) |
| Mar 2016 | - | $12.13 M(-2.3%) |
| Dec 2015 | $25.98 M(+292.0%) | $12.41 M(+100.1%) |
| Sep 2015 | - | $6.20 M |
| Dec 2014 | $6.63 M | - |
FAQ
- What is CRISPR Therapeutics AG annual total operating expenses?
- What is the all time high annual operating expenses for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual operating expenses year-on-year change?
- What is CRISPR Therapeutics AG quarterly total operating expenses?
- What is the all time high quarterly operating expenses for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly operating expenses year-on-year change?
What is CRISPR Therapeutics AG annual total operating expenses?
The current annual operating expenses of CRSP is $391.32 M
What is the all time high annual operating expenses for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual total operating expenses is $563.35 M
What is CRISPR Therapeutics AG annual operating expenses year-on-year change?
Over the past year, CRSP annual total operating expenses has changed by -$70.97 M (-15.35%)
What is CRISPR Therapeutics AG quarterly total operating expenses?
The current quarterly operating expenses of CRSP is $99.59 M
What is the all time high quarterly operating expenses for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly total operating expenses is $149.50 M
What is CRISPR Therapeutics AG quarterly operating expenses year-on-year change?
Over the past year, CRSP quarterly total operating expenses has changed by +$459.00 K (+0.46%)